TWI347364B - Inactivated nodavirus vaccine - Google Patents

Inactivated nodavirus vaccine

Info

Publication number: TWI347364B
Authority: TW; Taiwan
Prior art keywords: vaccine; inactivated; inactivated nodavirus; nodavirus vaccine; fish
Prior art date: 2003-02-19

Application number

TW093103736A

Other languages

English (en)

Other versions

TW200425899A (en

Inventor

Santos Nuno Dos

Jacqueline Ireland

Andrew Cartner Barnes

Michael Horne

Original Assignee

Novartis Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-02-19

Filing date

2004-02-17

Publication date

2011-08-21

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=32910468&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=TWI347364(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2003-02-19 Priority claimed from GB0303867A external-priority patent/GB0303867D0/en

2003-08-28 Priority claimed from GB0320195A external-priority patent/GB0320195D0/en

2004-02-17 Application filed by Novartis Ag filed Critical Novartis Ag

2004-12-01 Publication of TW200425899A publication Critical patent/TW200425899A/zh

2011-08-21 Application granted granted Critical

2011-08-21 Publication of TWI347364B publication Critical patent/TWI347364B/zh

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5252—Virus inactivated (killed)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/30011—Nodaviridae
- C12N2770/30034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/30011—Nodaviridae
- C12N2770/30061—Methods of inactivation or attenuation
- C12N2770/30063—Methods of inactivation or attenuation by chemical treatment

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Virology (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Organic Chemistry (AREA)
Microbiology (AREA)
Zoology (AREA)
Wood Science & Technology (AREA)
Genetics & Genomics (AREA)
Immunology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Biochemistry (AREA)
Epidemiology (AREA)
General Engineering & Computer Science (AREA)
Mycology (AREA)
Biomedical Technology (AREA)
Biotechnology (AREA)
Chemical Kinetics & Catalysis (AREA)
Communicable Diseases (AREA)
General Chemical & Material Sciences (AREA)
Oncology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Farming Of Fish And Shellfish (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

TW093103736A 2003-02-19 2004-02-17 Inactivated nodavirus vaccine TWI347364B (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GB0303867A GB0303867D0 (en)	2003-02-19	2003-02-19	Organic compounds
GB0320195A GB0320195D0 (en)	2003-08-28	2003-08-28	Organic compounds

Publications (2)

Publication Number	Publication Date
TW200425899A TW200425899A (en)	2004-12-01
TWI347364B true TWI347364B (en)	2011-08-21

Family

ID=32910468

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
TW093103736A TWI347364B (en)	2003-02-19	2004-02-17	Inactivated nodavirus vaccine

Country Status (17)

Country	Link
US (2)	US20060257425A1 (zh)
EP (1)	EP1597359B1 (zh)
JP (1)	JP4664901B2 (zh)
AT (1)	ATE437224T1 (zh)
AU (1)	AU2004213566B2 (zh)
CA (1)	CA2512930C (zh)
CL (1)	CL2004000282A1 (zh)
CY (1)	CY1109344T1 (zh)
DE (1)	DE602004022139D1 (zh)
DK (1)	DK1597359T3 (zh)
ES (1)	ES2328141T3 (zh)
MY (1)	MY143785A (zh)
NO (1)	NO336878B1 (zh)
PT (1)	PT1597359E (zh)
SI (1)	SI1597359T1 (zh)
TW (1)	TWI347364B (zh)
WO (1)	WO2004074467A1 (zh)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CL2008003262A1 (es) *	2007-11-02	2009-06-26	Intervet Int Bv	Vacuna que comprende lactococcus garviae, pasteurella piscicida, vibrio anguillarum y nocardia seriolae; y uso de dichas bacterias para combatir infecciones de nocardia en peces.
KR101608121B1 (ko) *	2012-09-20	2016-04-01	중앙대학교 산학협력단	노다바이러스의 바이러스 유사입자의 생산방법, 이를 발현하는 효모 세포주 및 이를 포함하는 백신 조성물
KR101414009B1 (ko) *	2012-11-16	2014-07-02	주식회사 젠닥스	형질전환 식물체를 이용한 어류 바이러스성 신경괴사증 예방 경구백신 제조방법과 그에 따른 식물체
US9884103B2 (en) *	2013-05-28	2018-02-06	Elanco Tiergesundheit Ag	Interactions of betanodaviruses in infection
ES2795040T3 (es) *	2016-02-02	2020-11-20	Benchmark Animal Health Ltd	Métodos para producir virus
CN113429338B (zh) *	2021-05-20	2023-05-02	陕西泰合利华工业有限公司	一种合成氟吡菌酰胺的方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5891705A (en) *	1997-04-08	1999-04-06	Pentose Pharmaceuticals, Inc.	Method for inactivating a virus
WO1999050419A2 (en) *	1998-03-31	1999-10-07	University Of Maryland Biotechnology Institute	A method for generating nonpathogenic, infectious pancreatic necrosis virus (ipnv) from synthetic rna transcripts
TWI220904B (en) *	1998-12-03	2004-09-11	Nat Science Council	An immortal cell line derived from grouper Epinephelus coioides and its applications therein
US20040001863A1 (en) *	1998-12-03	2004-01-01	Shau-Chi Chi	Immortal cell line derived from grouper Epinephelus coioides and its applications therein
JP2001161355A (ja) *	1999-11-25	2001-06-19	Natl Sci Council	ハタ科チャイロマルハタから得られる不死の細胞株およびその応用
AU2002233969A1 (en) *	2001-12-07	2003-06-23	Schweitzer Chemical Corporation Usa	Vaccines and antibodies produced from viruses derived from an immortal cell line of grouper epinephelus coioides
US20050118194A1 (en) *	2003-12-01	2005-06-02	Sin Yoke M.	Oral vaccine, method for its preparation and use thereof

2004
- 2004-02-17 TW TW093103736A patent/TWI347364B/zh not_active IP Right Cessation
- 2004-02-18 CA CA2512930A patent/CA2512930C/en not_active Expired - Lifetime
- 2004-02-18 AU AU2004213566A patent/AU2004213566B2/en not_active Expired
- 2004-02-18 EP EP04712006A patent/EP1597359B1/en not_active Expired - Lifetime
- 2004-02-18 ES ES04712006T patent/ES2328141T3/es not_active Expired - Lifetime
- 2004-02-18 DE DE602004022139T patent/DE602004022139D1/de not_active Expired - Lifetime
- 2004-02-18 JP JP2006501877A patent/JP4664901B2/ja not_active Expired - Lifetime
- 2004-02-18 DK DK04712006T patent/DK1597359T3/da active
- 2004-02-18 CL CL200400282A patent/CL2004000282A1/es unknown
- 2004-02-18 SI SI200431251T patent/SI1597359T1/sl unknown
- 2004-02-18 AT AT04712006T patent/ATE437224T1/de not_active IP Right Cessation
- 2004-02-18 PT PT04712006T patent/PT1597359E/pt unknown
- 2004-02-18 US US10/545,528 patent/US20060257425A1/en not_active Abandoned
- 2004-02-18 WO PCT/EP2004/001543 patent/WO2004074467A1/en not_active Ceased
- 2004-02-18 MY MYPI20040527A patent/MY143785A/en unknown
2005
- 2005-09-12 NO NO20054219A patent/NO336878B1/no unknown
2009
- 2009-04-16 US US12/425,135 patent/US8124100B2/en not_active Expired - Lifetime
- 2009-08-28 CY CY20091100898T patent/CY1109344T1/el unknown

Also Published As

Publication number	Publication date
US8124100B2 (en)	2012-02-28
US20060257425A1 (en)	2006-11-16
AU2004213566A1 (en)	2004-09-02
CA2512930C (en)	2015-06-02
AU2004213566B2 (en)	2007-08-23
ES2328141T3 (es)	2009-11-10
CL2004000282A1 (es)	2005-03-28
DK1597359T3 (da)	2009-11-16
EP1597359A1 (en)	2005-11-23
HK1085765A1 (zh)	2006-09-01
JP2006517943A (ja)	2006-08-03
NO20054219L (no)	2005-09-12
EP1597359B1 (en)	2009-07-22
WO2004074467A1 (en)	2004-09-02
ATE437224T1 (de)	2009-08-15
PT1597359E (pt)	2009-08-06
JP4664901B2 (ja)	2011-04-06
MY143785A (en)	2011-07-15
CA2512930A1 (en)	2004-09-02
DE602004022139D1 (zh)	2009-09-03
SI1597359T1 (sl)	2009-12-31
NO20054219D0 (no)	2005-09-12
US20090288179A1 (en)	2009-11-19
CY1109344T1 (el)	2014-07-02
TW200425899A (en)	2004-12-01
NO336878B1 (no)	2015-11-23

Publication	Publication Date	Title
WO2004060308A3 (en)	2006-10-05	Thiosemicarbazones as anti-virals and immunopotentiators
CY1109344T1 (el)	2014-07-02	Εμβολιο αδρανοποιημενου nodavirus
EA200501689A1 (ru)	2006-06-30	Соединения в качестве ингибиторов вируса гепатита c
EA200900156A1 (ru)	2009-06-30	Пиридазиновое соединение (варианты), способ его получения (варианты), способ лечения или профилактики инфекционного вирусного гепатита с с его помощью, композиция и лекарственное средство на его основе
GEP20063938B (en)	2006-10-10	Hepatitis c virus inhibitors
EA200500584A1 (ru)	2006-02-24	Нуклеозидные производные для лечения инфекционных заболеваний, вызванных вирусом гепатита c
DE60226911D1 (de)	2008-07-10	Entwicklung einer Vakzine zur Prävention von Infektionen mit Filovirus bei Primaten
TW200730478A (en)	2007-08-16	N-(6-membered aromatic ring)-amido anti-viral compounds
NO20070751L (no)	2007-05-07	Inhibitorer av HCV-replifikasjon
EA200700243A1 (ru)	2007-08-31	Способы лечения гепатита с
DK1569929T3 (da)	2010-08-16	Forbindelser og fremgangsmåder til behandling eller forebyggelse af flavi-virusinfektioner
IS8591A (is)	2007-01-17	Ný notkun
WO2007002470A3 (en)	2007-11-01	Inactivated chimeric vaccines and related methods of use
WO2019222238A3 (en)	2019-12-26	Substituted 2,2'-bipyrimidinyl compounds, analogues thereof, and methods using same
ATE455124T1 (de)	2010-01-15	Rekombinante vesicular stomatitis viren als impstoff gegen virale hämorrhagische fieber
DK1395283T3 (da)	2007-07-09	Heterolog beskyttelse induceret ved immunisering med Invaplex-vaccine
EA200801251A1 (ru)	2008-12-30	Вакцины против гриппа, адсорбированные на алюминиевых адъювантах, для немедленного приёма
ATE401392T1 (de)	2008-08-15	Subtypabgestimmte inaktivierte vollvirusvakzine zur behandlung von patienten mit hiv-infektion
AR019785A1 (es)	2002-03-13	Pestivirus no diseminantes
MX2007002659A (es)	2007-05-16	Composicion vacunal contra el virus de la hepatitis c.
DE60224026D1 (de)	2008-01-24	Rechen
DE60238554D1 (de)	2011-01-20	Vakzine gegen infektionskrankheiten
WO2003054176A3 (en)	2004-05-06	Preparation of vaccines using photosensitizer and light
DE60040792D1 (de)	2008-12-24	Stress-protein-peptidkomplexe als impfstoffe gegen intrazelluläre pathogene
TW200621800A (en)	2006-07-01	Human immunodeficiency virus vaccine

Legal Events

Date	Code	Title	Description
2024-04-01	MK4A	Expiration of patent term of an invention patent